Christopher R. M. Asquith

Author

University of North Carolina at Chapel Hill ORCID

Also Known As

Asquith, Christopher, Asquith, Christopher R M, Asquith, Christopher R. M., Asquith, Christopher R.M., Asquith, Christopher RM, C Asquith, C. Asquith, Christopher Asquith, Christopher R M Asquith, Christopher R. M. Asquith

163

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Eastern Finland University of Southampton Universidade Estadual de Campinas (UNICAMP)University College London

About

Christopher R. M. Asquith is an author at University of North Carolina at Chapel Hill specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	430
2	Natural Sciences	5	5	259
3	Biochemistry	2	2	28
4	Biomolecular Engineering	2	2	55
5	Engineering	1	1	58

Christopher R. M. Asquith

Publications

842

Citations

H-Index

Page 1

	Year	Citations
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification Carrow I. Wells, Hassan Al‐Ali, David Andrews, International Journal of Molecular Sciences Drug TargetSelective Kinase InhibitorsMolecular BiologyBioinformatics DatabaseTumor Biology	2021	105
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK) Christopher R. M. Asquith, Benedict‐Tilman Berger, Jing Wan, Journal of Medicinal Chemistry Collateral TargetMolecular BiologyCell CycleCellular PhysiologySignaling Pathway	2019	68
Three-Dimensional Printing of a Scalable Molecular Model and Orbital Kit for Organic Chemistry Teaching and Learning Matthew R. Penny, Zi Jing Cao, Bhaven Patel, Journal of Chemical Education Materials ScienceOrbital ModelsEngineeringNatural SciencesDesign	2017	58
Identification and Optimization of 4‐Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase Christopher R. M. Asquith, Tuomo Laitinen, James M. Bennett, ChemMedChem	2017	57
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma Christopher R. M. Asquith, Kaleb M. Naegeli, Michael P. East, Journal of Medicinal Chemistry Tumor BiologyGak InhibitionMedicineReceptor Tyrosine KinasePharmacology	2019	41
Targeting an EGFR Water Network with 4‐Anilinoquin(az)oline Inhibitors for Chordoma Christopher R. M. Asquith, Kaitlyn Maffuid, Tuomo Laitinen, ChemMedChem	2019	39
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies Marwah Karim, Sirle Saul, Luca Ghita, Antiviral Research Sars-cov-2 InfectionMedicineCellular TargetsViral PathogenesisImmunology	2022	38
Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection Christopher R. M. Asquith, Theres Meili, Tuomo Laitinen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryFeline Immunodeficiency VirusMedicineDrug DiscoveryHiv Infection	2019	34
Quinazoline-Based Antivirulence Compounds Selectively Target <i>Salmonella</i> PhoP/PhoQ Signal Transduction System María Ayelén Carabajal, Christopher R. M. Asquith, Tuomo Laitinen, Antimicrobial Agents and Chemotherapy	2019	33
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes Benjamin J. Eduful, Sean O’Byrne, Louisa Temme, Journal of Medicinal Chemistry	2021	32

Page 1